STAT

JULY 6, 2023

Traumatic brain injury multiplies the risk of major depression eightfold. While the emotional trauma of whatever caused such deep damage may be understandable, from a blast in a war zone to a blow on the playing field, there’s a physiological component, too, that neuroscientists have long suspected but have been unable to identify. “As clinicians, a lot of us had a gut feeling that [TBI-associated depression] is a different disease,” said Shan Siddiqi, a Harvard Medical Scho

Medical Schools 252

Medical Schools Hospitals 252

PharmaVoice

JULY 6, 2023

New lawsuits challenging the Inflation Reduction Act’s price negotiation program hit the government with multiple Constitution-based challenges.

246

246

STAT

JULY 6, 2023

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest. The drug, called Leqembi , was developed by Eisai , the Japanese pharmaceutical company, and sold in partnership with Biogen.

Pharmaceutical Companies 252

Pharmaceutical Companies Pharmaceutical Companies 252

BioPharma Dive

JULY 6, 2023

Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 6, 2023

When then-Vice President Biden launched the Cancer Moonshot in 2016, there was reason to be optimistic. Decades of rigorous science had transformed many cancers from a death sentence to a manageable chronic disease. New treatment advances — including gene and cell therapies and immunotherapies — were showing stunning results. With support from the biopharmaceutical industry and the help of smart government policies, ending cancer was, and is, an achievable goal.

246

246

PharmExec

JULY 6, 2023

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

98

98

The Pharmacist

JULY 6, 2023

The community pharmacy sector can help design a solution to the needs of the health service if NHS England and the Department of Health and Social Care (DHSC) set out a clear vision for what they want, and how they are going to pay for it, the chief executive of the Company Chemists’ Association (CCA) […] The post CCA chief: NHS and DHSC must decide what they want – and how they will pay for it appeared first on The Pharmacist.

Community Pharmacies 96

Community Pharmacies 96

STAT

JULY 6, 2023

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition. At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm.

234

234

The Pharmacist

JULY 6, 2023

Superdrug has appointed Ghada Beal – a pharmacist by background – as its new healthcare director, it has been announced. Ms Beal, who is set to join Superdrug next month, said she was committed to help continue developing ways in which the company ‘supports the diverse healthcare needs of all communities’. Her appointment comes amid […] The post Superdrug appoints new healthcare director with pharmacy background appeared first on The Pharmacist.

88

88

STAT

JULY 6, 2023

Drinking water from nearly half of U.S. faucets likely contains “forever chemicals” that may cause cancer and other health problems, according to a government study released Wednesday. The synthetic compounds known collectively as PFAS are contaminating drinking water to varying extents in large cities and small towns — and in private wells and public systems, the U.S.

Compounding 229

Compounding 229

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

JULY 6, 2023

Negotiations between Community Pharmacy England (CPE), ministers and NHS England on a new national Pharmacy First scheme are ‘on track’ to reach agreement this month. Under the current timescales, it has been suggested that a range of expanded pharmacy services announced in May could also be implemented in July. In a statement to the sector […] The post Pharmacy services negotiations ‘on track’ to conclude this month appeared first on The Pharmacist.

Community Pharmacies 86

Community Pharmacies 86

STAT

JULY 6, 2023

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits. The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health.

Diabetes 215

Diabetes 215

Outsourcing Pharma

JULY 6, 2023

This yearâs CPHI South East Asia is expecting a surge in international partnering with organizers expecting a record attendance of 8,000 visitors including a significant number from overseas â doubling last yearâs figures.

93

93

STAT

JULY 6, 2023

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription dr

Drug Pricing 200

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 200

Pharma Times

JULY 6, 2023

European Innovation Council Accelerator finances treatment development drive for condition - News - PharmaTimes

112

112

STAT

JULY 6, 2023

The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law that is designed to provide transparency into prescription drug pricing is unconstitutional, the latest effort to push back against states attempting to lower the cost of medicines. In its lawsuit , the Association for Accessible Medicines claimed the law is an “unconstitutional overreach,” because it gives the state the power to regulate interstate commerce and apply Minnesota law to prices cha

Drug Pricing 192

Drug Pricing 192

Pharmaceutical Technology

JULY 6, 2023

Lifera, Arabio and Sanofi have signed a memorandum of understanding (MOU) to bolster manufacturing of vaccines in Saudi Arabia.

Vaccines 111

Vaccines 111

STAT

JULY 6, 2023

Mercy Philadelphia Hospital was planning on shutting down. Losing Mercy, a safety-net hospital serving a predominantly low-income and Black community, would have created a health care desert in West Philadelphia. “It would have been easy for us to just absorb it into our existing hospital beds,” said Kevin Mahoney, CEO of the University of Pennsylvania Health System.

Hospitals 183

Hospitals 183

BioPharma Dive

JULY 6, 2023

The broader approval is expected to push insurers, namely Medicare, to increase coverage of so-called amyloid-targeting therapies.

109

109

STAT

JULY 6, 2023

Top of the morning to you, and a fine one it is. Cool breezes and clear blue skies – at least for now – are wafting above the Pharmalot campus, where the official mascots are settling in for a well-deserved snooze. As for us, we are busy with the usual sorts of things. We are quaffing another cup of stimulation – our choice today is gingerbread – are attempting to get organized, a Quixotic notion in our world.

Drug Pricing 151

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 151

pharmaphorum

JULY 6, 2023

In our penultimate video from ASCO 2023, Editor in Chief Jonah Comstock touches base with Biofourmis Chief Operating Officer Jaydev Thakkar. Biofourmis works with pharma on accelerating drug development and with post-market monitoring of approved drugs.

Drug Development 91

Drug Development 91

European Pharmaceutical Review

JULY 6, 2023

BioNTech SE and the UK government have jointly agreed to provide up to 10,000 patients with personalised cancer immunotherapies by 2030. Signing of this agreement builds on a memorandum of understanding signed in January. The partnership will provide cancer patients with improved access to the latest cancer trials and therapies currently being developed.

Vaccines 91

Vaccines 91

Outsourcing Pharma

JULY 6, 2023

With the FDA issuing guidance on more diversity within clinical trials, it is a subject many companies are being encouraged to focus on, each with their own approach.

83

83

Pharma Times

JULY 6, 2023

Patients treated with Kesimpta experienced considerable decreases in relapse rates - News - PharmaTimes

102

102

Pharmaceutical Technology

JULY 6, 2023

The ICMRA says evidence from more than 13 billion global vaccine doses shows good safety amid “dangerous” false information.

Vaccines 98

Vaccines 98

pharmaphorum

JULY 6, 2023

In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP of Global Talent and Client Delivery James Nyssen speak with host Jonah Comstock about findings from a recent report by their company on the current personnel dynamics in pharma.

80

80

Pharmaceutical Technology

JULY 6, 2023

SK bioscience and Thailand's GPO have entered a memorandum of understanding (MoU) to bolster vaccine infrastructure in Thailand.

Vaccines 90

Vaccines 90

Big Molecule Watch

JULY 6, 2023

In the last week, seven adalimumab biosimilars referencing HUMIRA entered the U.S. market: Boehringer Ingelheim’s CYLTEZO (adalimumab-adbm); Sandoz’s HYRIMOZ (adalimumab-adaz); Organon and Samsung Bioepis’s HADLIMA (adalimumab-bwwd); Coherus Biosciences’s YUSIMRY (adalimumab-aqvh); Celltrion’s YUFLYMA (adalimumab-aaty); Fresenius Kabi’s IDACIO (adalimumab-aacf); and Biocon’s HULIO (adalimumab-fkjb).

Biosimilars 67

Biosimilars 67

Outsourcing Pharma

JULY 6, 2023

Toenail fungus is an embarrassing problem to have but Scottish health tech firm, Emblation is hopeful its treatment could prove effective.

71

71

pharmaphorum

JULY 6, 2023

Changing Faces: Agency, consultancy, and investor hires from June 2023 Mike.

97

97

BioPharma Dive

JULY 6, 2023

Some industry watchers predict activity could soon pick up, as market conditions improve and a mix of cash-strapped startups as well as advanced biotechs test the waters.

62

62

PharmExec

JULY 6, 2023

Pharma is built to overcome, but focus on fundamentals remains key.

98

98

BioPharma Dive

JULY 6, 2023

The deal comes three months after VBI cut costs and laid off staff in a restructuring meant to prioritize the two medicines Brii is interested in.

65

65

pharmaphorum

JULY 6, 2023

Study shows psilocybin offers cost-effective solution for major depression Eloise.

85

85

BioPharma Dive

JULY 6, 2023

The eye care company has become an active acquirer under new CEO Brent Saunders, buying an eye drop product line one week after purchasing several medicines from Novartis.

55

55